Clinical Trial Update: Radiofrequency Ablation of Pulmonary Tumors Response Evaluation [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating radiofrequency ablation of pulmonary tumors has completed, focusing on response evaluation for non-small cell lung cancer and pulmona…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Pulmonary Metastases

Drugs mentioned

• Radiofrequency Ablation Device

Snippet

Sponsor: Angiodynamics, Inc. | Conditions: Non Small Cell Lung Cancer, Pulmonary Metastases | Phase 2 | Status: COMPLETED